Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Okuyama Dobashi, Kaori ^a   Kasai, Hirotake ^a   Tanaka, Tomohisa ^a   Yamashita, Atsuya ^a   Yasumoto, Jun ^a   Chen, Wenjia ^a   Okamoto, Toru ^b   Maekawa, Shinya ^a   Watashi, Koichi ^c   Wakita, Takaji ^c   Ryo, Akihide ^d   Suzuki, Tetsuro ^e   Matsuura, Yoshiharu ^b   Enomoto, Nobuyuki ^a   Moriishi, Kohji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZELASTINE; BUFADIENOLIDE DERIVATIVE; BUFALIN; CONVALLATOXIN; COTRANSPORTER; DIGITOXIN; DIGOXIN; L PROTEIN, HEPATITIS B VIRUS; ORGANIC ANION TRANSPORTER; PHTHALAZINE DERIVATIVE; PROSCILLARIDIN; SIMVASTATIN; SODIUM-BILE ACID COTRANSPORTER; STROPHANTHIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ANTAGONISTS AND INHIBITORS; CELL ADHESION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEP-G2 CELL LINE; HEPATITIS B VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; PHYSIOLOGY; TRANSGENE; VIRUS ENTRY;

ANTIVIRAL AGENTS; BUFANOLIDES; CELL ADHESION; DIGITOXIN; DIGOXIN; GENE EXPRESSION; HEP G2 CELLS; HEPATITIS B VIRUS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PHTHALAZINES; PROSCILLARIDIN; RECEPTORS, VIRUS; SIMVASTATIN; STROPHANTHINS; SYMPORTERS; TRANSGENES; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84947940826     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17047     Document Type: Article

References (30)

1. El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264-1273 e1 (2012).
2. Kwon, H. & Lok, A. S. Hepatitis B therapy. Nat. Rev. Gastroenterol. Hepatol. 8, 275-84 (2011).
3. Glebe, D. & Urban, S. Viral and cellular determinants involved in hepadnaviral entry. World. J. Gastroenterol. 13, 22-38 (2007).
4. Urban, S., Bartenschlager, R., Kubitz, R. & Zoulim, F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 147, 48-64 (2014).
5. Leistner, C. M., Gruen-Bernhard, S. & Glebe, D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell. Microbiol. 10, 122-33 (2008).
6. Sureau, C. & Salisse, J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57, 985-94 (2013).
7. Glebe, D., et al. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 77, 9511-21 (2003).
8. Glebe, D., et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129, 234-45 (2005).
9. Gripon, P., Cannie, I. & Urban, S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 79, 1613-22 (2005).
10. Engelke, M., et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43, 750-60 (2006).
11. Yan, H., et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, e00049 (2012).
12. Ni, Y., et al. Hepatitis B and D viruses exploit sodium taurocholate co-Dransporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070-83 (2014).
13. Yan, H., et al. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J. Virol. 87, 7977-91 (2013).
14. Yan, H., et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J. Virol. 88, 3273-84 (2014).
15. Meier, A., Mehrle, S., Weiss, T. S., Mier, W. & Urban, S. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 58, 31-42 (2013).
16. Iwamoto, M., et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem. Biophys. Res. Commun. 443, 808-13 (2014).
17. Park, I H., Kwon, Y. C., Ryu, W. S. & Ahn, B. Y. Inhibition of Hepatitis B Virus Replication by Ligand-mediated Activation of RNase L. Antiviral Res. 104, 118-27 (2014).
18. Schulze, A., Mills, K., Weiss, T. S. & Urban, S. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55, 373-83 (2012).
19. Liu, Y., Ganguly, T., Hyde, J. F. & Vore, M. Prolactin increases mRNA encoding Na(+ )-DC cotransport polypeptide and hepatic Na(+ )-DC cotransport. Am. J. Physiol. 268, G11-7 (1995).
20. Stieger, B., et al. In situ localization of the hepatocytic Na+ /Taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107, 1781-7 (1994).
21. Sun, A. Q., et al. The rat liver Na(+ )/bile acid cotransporter. Importance of the cytoplasmic tail to function and plasma membrane targeting. J. Biol. Chem. 276, 6825-33 (2001).
22. Konig, A., et al. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+ /taurocholate cotransporting polypeptide (NTCP) in hepatocytes. J. Hepatol. 61, 867-75 (2014).
23. Watashi, K., et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology 59, 1726-37 (2014).
24. Fu, L. L., et al. In silico analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate cotransporting polypeptide (NTCP) in HBV therapy. Cell Prolif. 47, 326-35 (2014).
25. Gozalpour, E., et al. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. Mol. Pharm. 11, 1844-55 (2014).
26. Greupink, R., Dillen, L., Monshouwer, M., Huisman, M. T. & Russel, F. G. Interaction of fluvastatin with the liver-specific Na+-dependent taurocholate cotransporting polypeptide (NTCP). Eur. J. Pharm. Sci. 44, 487-96 (2011).
27. Tsan, Y. T., Lee, C. H., Wang, J. D. & Chen, P. C. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J. Clin. Oncol. 30, 623-30 (2012).
28. Hawkins, C. J., Uren, A. G., Hacker, G., Medcalf, R. L. & Vaux, D. L. Inhibition of interleukin 1 beta-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP. Proc. Natl. Acad. Sci. USA 93, 13786-90 (1996).
29. Ogura, N., Watashi, K., Noguchi, T. & Wakita, T. Formation of covalently closed circular DNA in Hep38.7-Det cells, a tetracycline inducible hepatitis B virus expression cell line. Biochem. Biophys. Res. Commun. 452, 315-21 (2014).
30. Ladner, S. K., et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents. Chemother. 41, 1715-20 (1997).